Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-02 5:40 pm Purchase | 2025-03-31 | 13G | IMMATICS N V IMTX | SUVRETTA CAPITAL MANAGEMENT LLC | 9,135,029 7.500% | 1,253,421 (+15.90%) | Filing History |
| 2025-05-02 5:37 pm Purchase | 2025-03-31 | 13G | 89BIO INC ETNB | SUVRETTA CAPITAL MANAGEMENT LLC | 14,611,409 9.900% | 4,408,713 (+43.21%) | Filing History |
| 2025-05-02 5:33 pm Purchase | 2025-03-31 | 13G | FULCRUM THERAPEUTICS INC FULC | SUVRETTA CAPITAL MANAGEMENT LLC | 5,067,394 9.400% | 1,662,782 (+48.84%) | Filing History |
| 2025-05-02 5:16 pm Purchase | 2025-03-31 | 13G | KURA ONCOLOGY INC KURA | SUVRETTA CAPITAL MANAGEMENT LLC | 7,561,000 9.400% | 2,362,811 (+45.45%) | Filing History |
| 2025-05-02 5:14 pm Purchase | 2021-06-15 | 13G | MOLECULAR PARTNERS AG ADS MOLN | SUVRETTA CAPITAL MANAGEMENT LLC | 4,284,806 10.600% | 4,284,806 (New Position) | Filing History |
| 2025-04-16 5:30 pm Purchase | 2025-04-09 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | SUVRETTA CAPITAL MANAGEMENT LLC | 3,360,000 5.500% | 3,360,000 (New Position) | Filing History |
| 2025-04-11 5:57 pm Purchase | 2025-04-04 | 13G | AURA BIOSCIENCES INC AURA | SUVRETTA CAPITAL MANAGEMENT LLC | 3,057,319 6.100% | 3,057,319 (New Position) | Filing History |
| 2025-04-11 4:46 pm Purchase | 2025-04-07 | 13G | DBV TECHNOLOGIES S.A. ADR DBVT | SUVRETTA CAPITAL MANAGEMENT LLC | 15,176,015 9.900% | 15,176,015 (New Position) | Filing History |
| 2025-03-28 4:50 pm Purchase | 2025-03-26 | 13D | BENITEC BIOPHARMA INC BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 15,623,659 49.900% | 1,293,722 (+9.03%) | Filing History |
| 2025-03-11 7:22 pm Purchase | 2025-03-04 | 13G | WHITEHAWK THERAPEUTICS, INC. C WHWK | SUVRETTA CAPITAL MANAGEMENT LLC | 4,727,510 9.990% | 4,727,510 (New Position) | Filing History |
| 2025-02-13 8:15 pm Sale | 2024-12-31 | 13G | KURA ONCOLOGY INC KURA | SUVRETTA CAPITAL MANAGEMENT LLC | 5,198,189 6.700% | -2,274,154 (-30.43%) | Filing History |
| 2025-02-13 8:09 pm Sale | 2024-12-31 | 13G | ERASCA INC ERAS | SUVRETTA CAPITAL MANAGEMENT LLC | 12,315,004 4.400% | -1,453,035 (-10.55%) | Filing History |
| 2025-02-13 8:00 pm Purchase | 2024-12-31 | 13G | 89BIO INC ETNB | SUVRETTA CAPITAL MANAGEMENT LLC | 10,202,696 8.500% | 2,211,052 (+27.67%) | Filing History |
| 2025-02-11 8:51 pm Purchase | 2025-02-04 | 13G | IMMATICS N V IMTX | SUVRETTA CAPITAL MANAGEMENT LLC | 7,881,608 6.500% | 7,881,608 (New Position) | Filing History |
| 2025-02-11 8:45 pm Purchase | 2025-02-07 | 13G | MARINUS PHARMACEUTICALS INC MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 3,022,612 5.500% | 917,348 (+43.57%) | Filing History |
| 2025-02-11 8:20 pm Sale | 2024-12-31 | 13G | MARINUS PHARMACEUTICALS INC MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 2,105,264 3.800% | -3,358,377 (-61.47%) | Filing History |
| 2025-02-07 5:36 pm Purchase | 2025-02-05 | 13G | PEPGEN INC PEPG | SUVRETTA CAPITAL MANAGEMENT LLC | 1,660,932 5.100% | 486,611 (+41.44%) | Filing History |
| 2025-02-07 5:16 pm Sale | 2024-12-31 | 13G | PEPGEN INC PEPG | SUVRETTA CAPITAL MANAGEMENT LLC | 1,174,321 3.600% | -486,611 (-29.30%) | Filing History |
| 2025-01-06 4:50 pm Purchase | 2024-12-27 | 13G | FULCRUM THERAPEUTICS INC FULC | SUVRETTA CAPITAL MANAGEMENT LLC | 3,404,612 6.300% | 2,221,821 (+187.85%) | Filing History |
| 2024-12-20 4:56 pm Purchase | 2024-12-13 | 13G | PALVELLA THERAPEUTICS INC PVLA | SUVRETTA CAPITAL MANAGEMENT LLC | 714,463 8.600% | 714,463 (New Position) | Filing History |